Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse - PubMed (original) (raw)
Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse
Qingbo Wang et al. Methods Mol Biol. 2017.
Abstract
The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system is a prominent genome engineering technology. In the CRISPR/Cas system, the RNA-guided endonuclease Cas protein introduces a DNA double-stranded break at the genome position recognized by a guide RNA (gRNA) based on complementary base-pairing of about 20-nucleotides in length. The 8- or 12-mer gRNA sequence in the proximal region is especially important for target recognition, and the genes with sequence complementarity to such regions are often disrupted. To carry out target site-specific genome editing, we released the CRISPRdirect ( http://crispr.dbcls.jp /) website. This website allows us to select target site-specific gRNA sequences by performing exhaustive searches against entire genomic sequences. In this study, target site-specific gRNA sequences were designed for human, mouse, Drosophila melanogaster, and Caenorhabditis elegans. The calculation results revealed that at least five gRNA sequences, each of them having only one perfectly complementary site in the whole genome, could be designed for more than 95% of genes, regardless of the organism. Next, among those gRNAs, we selected gRNAs that did not have any other complementary site to the unique 12-mer proximal sequences to avoid possible off-target effects. This computational prediction revealed that target site-specific gRNAs are selectable for the majority of genes in D. melanogaster and C. elegans. However, for >50% of genes in humans and mice, there are no target sites without possible off-target effects.
Keywords: CRISPR direct; CRISPR/Cas9; Off-target gene; Target site.
Similar articles
- CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites.
Naito Y, Hino K, Bono H, Ui-Tei K. Naito Y, et al. Bioinformatics. 2015 Apr 1;31(7):1120-3. doi: 10.1093/bioinformatics/btu743. Epub 2014 Nov 20. Bioinformatics. 2015. PMID: 25414360 Free PMC article. - CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
Zhu LJ, Holmes BR, Aronin N, Brodsky MH. Zhu LJ, et al. PLoS One. 2014 Sep 23;9(9):e108424. doi: 10.1371/journal.pone.0108424. eCollection 2014. PLoS One. 2014. PMID: 25247697 Free PMC article. - An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome.
Hay EA, Khalaf AR, Marini P, Brown A, Heath K, Sheppard D, MacKenzie A. Hay EA, et al. Neuropeptides. 2017 Aug;64:101-107. doi: 10.1016/j.npep.2016.11.003. Epub 2016 Nov 4. Neuropeptides. 2017. PMID: 27866656 Free PMC article. - Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH, Adikaram P, Pandey M, Genis A, Simonds WF. Zhang JH, et al. Bioengineered. 2016 Apr;7(3):166-74. doi: 10.1080/21655979.2016.1189039. Bioengineered. 2016. PMID: 27340770 Free PMC article. Review. - Creating Heritable Mutations in Drosophila with CRISPR-Cas9.
Port F, Bullock SL. Port F, et al. Methods Mol Biol. 2016;1478:145-160. doi: 10.1007/978-1-4939-6371-3_7. Methods Mol Biol. 2016. PMID: 27730579 Review.
Cited by
- Historic Overview of Genetic Engineering Technologies for Human Gene Therapy.
Tamura R, Toda M. Tamura R, et al. Neurol Med Chir (Tokyo). 2020 Oct 15;60(10):483-491. doi: 10.2176/nmc.ra.2020-0049. Epub 2020 Sep 8. Neurol Med Chir (Tokyo). 2020. PMID: 32908085 Free PMC article. Review. - Therapeutic application of the CRISPR system: current issues and new prospects.
Lee M, Kim H. Lee M, et al. Hum Genet. 2019 Jun;138(6):563-590. doi: 10.1007/s00439-019-02028-2. Epub 2019 May 21. Hum Genet. 2019. PMID: 31115652 Review. - CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
Cullot G, Boutin J, Toutain J, Prat F, Pennamen P, Rooryck C, Teichmann M, Rousseau E, Lamrissi-Garcia I, Guyonnet-Duperat V, Bibeyran A, Lalanne M, Prouzet-Mauléon V, Turcq B, Ged C, Blouin JM, Richard E, Dabernat S, Moreau-Gaudry F, Bedel A. Cullot G, et al. Nat Commun. 2019 Mar 8;10(1):1136. doi: 10.1038/s41467-019-09006-2. Nat Commun. 2019. PMID: 30850590 Free PMC article. - Regulatory SNPs and their widespread effects on the transcriptome.
Merkulov VM, Leberfarb EY, Merkulova TI. Merkulov VM, et al. J Biosci. 2018 Dec;43(5):1069-1075. J Biosci. 2018. PMID: 30541964 Review. - While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action.
He Y, Yuan C, Chen L, Liu Y, Zhou H, Xu N, Liao DJ. He Y, et al. Int J Med Sci. 2018 Jan 19;15(4):309-322. doi: 10.7150/ijms.23215. eCollection 2018. Int J Med Sci. 2018. PMID: 29511367 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous